PROFFERED PAPERS
Tuesday, March 9   —  8:00 AM   —  Hall A


Click on the numbers in parentheses to display abstracts.



Section D - GENITOURINARY PATHOLOGY
Chaired by: Lars A. Egevad and Peter Humphrey



8:00 Cytokeratin 20(CK 20) and Ki-67 as Markers of Urothelial Dysplasia (681)
LP Kunju, M Snyder, C Lee, J Montie, RB Shah - University of Michigan Hospitals, Ann Arbor, MI
8:15 Prostate Cancer Staging: Recommendations for Modifying the 2002 AJCC Pathology Staging System Based on Accuracy in Reflecting Prognosis (730)
MA Rubin, A Dash, JT Wei, R Dunn, MG Sanda - Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA; Univeristy of Michigan School of Medicine, Ann Arbor, MI
8:30 Fat Invasion in Ten-Core Prostate Needle Biopsies: Incidence, Biopsy and Clinical Findings (778)
A Yilmaz, K Trpkov - Rockyview General Hospital, Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada
8:45 Use of Radical Prostatecomy Specimens To Assess the Utility of Saturation Biopsy To Predict "Insignificant" Cancer (624)
JI Epstein, H Sanderson, DO Scharfstein - The Johns Hopkins Hospital, Baltimore, MD; The Bloomberg School of Public Health, Baltimore, MD
9:00 Positive Bladder Neck Margin as the Sole Positive Margin at Radical Prostatectomy: Risk for Biochemical Progression (576)
H Aydin, T Tsuzuki, D Hernandez, JI Epstein - The Johns Hopkins Hospital, Baltimore, MD
9:15 The Significance of Bladder Neck Invasion in Radical Prostatectomy Specimens: Evidence Supporting the Current TNM Staging System (724)
CK Poulos, MO Koch, JN Eble, L Cheng - Indiana University School of Medicine, Indianapolis, IN
9:30 RECESS, EXHIBITS, POSTER SESSION III
11:00 VHL Gene Mutations in Multilocular Cystic Renal Cell Carcinoma: Evidence in Support of Its Classification as a Type of Clear Cell Renal Cell Carcinoma (645)
DJ Grignon, TA Bismar, F Bianco, WA Sakr, JE Pontes, F Sarkar, M Che - Harper University Hospital, the Karmanos Cancer Institute and Wayne State University, Detroit, MI
11:15 Unclassified Renal Cell Carcinoma: A Study of 45 Cases (712)
S Olgac, P Russo, VE Reuter - Memorial Sloan Kettering Cancer Center, New York City, NY
11:30 Pathological Characterization of Residual Prostate Cancer (PC) Following Chemotherapy Combined with Hormonal Ablation in the Neoadjuvant Surgical Model (559)
NA Abrahams, CA Pettaway, LL Pisters, TJ McDonnell, CJ Logothetis, P Troncoso - UT M.D. Anderson Cancer Center, Houston, TX
11:45 Microinvasive Germ Cell Neoplasia in Pure Seminomas: Associations with Poor Prognostic Parameters (595)
TJ Browne, MA Rubin - Brigham and Women's Hospital, Boston, MA; Harvard Medical Street, Boston, MA